- Profilerr
- CS2
- Pro Players
- Zygimage
ProfileEarnings
Zygimage’s profile
- Earnings
- $150
- Kills per round
- 0.6
- Headshots
- 31%
- Rounds
- 262
- Maps
- 11
- Matches
- 5
Average Zygimage’s Stats per Round
- Flash Assists
- 0.01
- KAST
- 68.24
- Assists
- 0.13
- ADR
- 67.84
- Deaths
- 0.71
- Rating
- N/A
Zygimage stats in the last 10 matches
Match | K (HS) | A (F) | Deaths | KD Diff | KAST | ADR | FK Diff | |
---|---|---|---|---|---|---|---|---|
W 2 : 0 L | Total | 18 (9) | 5 (0) | 39 | -21 | 63.35% | 56 | -6 |
Inferno | 9 (4) | 2 (0) | 19 | -10 | 57.1 | 49.2 | -2 | |
Ancient | 9 (5) | 3 (0) | 20 | -11 | 69.6 | 62.8 | -4 | |
L 0 : 2 W | Total | 33 (17) | 6 (1) | 29 | 4 | 75.3% | 74.2 | 2 |
Overpass | 17 (5) | 4 (0) | 18 | -1 | 76.9 | 74.2 | 3 | |
Ancient | 16 (12) | 2 (1) | 11 | 5 | 73.7 | 74.2 | -1 | |
L 1 : 2 W | Total | 59 (34) | 13 (1) | 46 | 13 | 80.17% | 77.77 | 1 |
Ancient | 19 (11) | 5 (0) | 16 | 3 | 74.1 | 71.4 | 2 | |
Inferno | 20 (14) | 5 (0) | 18 | 2 | 80 | 76.4 | 0 | |
Overpass | 20 (9) | 3 (1) | 12 | 8 | 86.4 | 85.5 | -1 | |
L 0 : 2 W | Total | 28 (11) | 5 (0) | 36 | -8 | 66% | 65.6 | 0 |
Nuke | 16 (6) | 1 (0) | 18 | -2 | 64 | 70.6 | 3 | |
Vertigo | 12 (5) | 4 (0) | 18 | -6 | 68 | 60.6 | -3 | |
L 0 : 2 W | Total | 20 (11) | 6 (0) | 36 | -16 | 50.4% | 60.65 | -1 |
Inferno | 5 (3) | 0 (0) | 17 | -12 | 36.8 | 45.7 | 0 | |
Nuke | 15 (8) | 6 (0) | 19 | -4 | 64 | 75.6 | -1 |
Matches
Wednesday 12 Apr 2023
W
NAVI Javelins
2 : 0
L
CPH Flames Female
ESL Impact League: European Division season 3 2023
Thursday 30 Mar 2023
Wednesday 29 Mar 2023
Thursday 16 Mar 2023
Wednesday 15 Mar 2023
L
CPH Flames Female
0 : 2
W
9 Pandas Fearless
ESL Impact League: European Division season 3 2023
Saturday 28 Jan 2023
Saturday 17 Dec 2022
W
Ninjas in Pyjamas Impact
1 : 0
L
CPH Flames Female
ESL Impact League Katowice: European Open Qualifier season 2 2023
Wednesday 14 Dec 2022
W
Astralis Female
1 : 0
L
CPH Flames Female
ESL Impact League Katowice: European Open Qualifier season 1 2023
Sunday 11 Dec 2022
Tournaments
Present and upcoming |
---|
We have no data at this time. |